Rheumatology / Rheumatoid Arthritis

clinical topic updates by Leonard H. Calabrese, DO

Controlling disease activity in rheumatoid arthritis (RA) appears to reduce cardiovascular (CV) risk, with risk reduction extending to the non–tumo...READ MORE

Rheumatology / Rheumatoid Arthritis

clinical topic updates by Jeffrey R. Curtis, MD, MS, MPH

While methotrexate (MTX) is considered the foundational drug for the treatment of rheumatoid arthritis (RA) and should be a component of the combin...READ MORE

Rheumatology / Rheumatoid Arthritis

patient care perspectives by Jeffrey R. Curtis, MD, MS, MPH

Up to half of individuals with rheumatoid arthritis (RA) cannot or will not take methotrexate (MTX). The appropriate treatment of patients with rel...READ MORE

Rheumatology / Rheumatoid Arthritis

patient care perspectives by Jonathan Kay, MD

In certain clinical scenarios, new diagnostic tests such as 14-3-3η protein and multi-biomarker disease activity (MBDA) have been shown to offer ad...READ MORE

Conference Reporter / Multiple Myeloma

conference reporter by Tom Iarocci, MD

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, ...READ MORE